Elanco Animal Health Inc

NYSE:ELAN   3:59:59 PM EDT
-0.14 (-0.44%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)14.99B
Current PEN/A
Forward PE 31.69
2yr Forward PE 24.95
See more stats
Estimates Current Quarter
Revenue$1.08 Billion
Adjusted EPS$0.17
See more estimates
10-Day MA$32.54
50-Day MA$33.55
200-Day MA$32.21
See more pivots

Elanco Animal Health Inc Stock, NYSE:ELAN

2500 Innovation Way, Greenfield, Indiana 46140
United States of America
Phone: +1.877.352.6261
Number of Employees: 9400


Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded on May 3, 2018 and is headquartered in Greenfield, IN.